These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6722255)

  • 21. Sulfated galactan is a catalyst of antithrombin-mediated inactivation of alpha-thrombin.
    Melo FR; Pereira MS; Monteiro RQ; Foguel D; Mourão PA
    Biochim Biophys Acta; 2008 Sep; 1780(9):1047-53. PubMed ID: 18558097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
    Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI
    Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure.
    Weber V; Linsberger I; Hauner M; Leistner A; Leistner A; Falkenhagen D
    Biomacromolecules; 2008 Apr; 9(4):1322-8. PubMed ID: 18345636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation.
    Ruzicka K; Wojta J; Artemiou O; Birsan T; Quehenberger P; Kapiotis S; Hofbauer R; Speiser W
    Life Sci; 1998; 63(17):1493-503. PubMed ID: 9808060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin.
    Björk I; Nordenman B
    Eur J Biochem; 1976 Sep; 68(2):507-11. PubMed ID: 976270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.
    Rezaie AR; Olson ST
    Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin-generation assay.
    Bourti Y; Fazavana J; Armand M; Saller F; Lasne D; Borgel D; Bianchini EP
    Thromb Haemost; 2016 Aug; 116(3):452-60. PubMed ID: 27412396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant activities of a monoclonal antibody that binds to exosite II of thrombin.
    Lian F; He L; Colwell NS; Lollar P; Tollefsen DM
    Biochemistry; 2001 Jul; 40(29):8508-13. PubMed ID: 11456488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of platelet-surface-bound proteins during coagulation under flow II: Antithrombin and heparin.
    Miyazawa K; Fogelson AL; Leiderman K
    Biophys J; 2023 Jan; 122(1):230-240. PubMed ID: 36325617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
    Stevic I; Berry LR; Chan AK
    J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of collagen on thrombin inactivation by antithrombin-III and heparin.
    Blaskó G; Bédi J; Machovich R; Pálos LA
    Haematologia (Budap); 1977; 11(1-2):163-8. PubMed ID: 615087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of anticoagulant activity of a novel heparinoid sulfated glucoside-bearing polymer.
    Sakamoto N; Kishida A; Maruyama I; Akashi M
    J Biomater Sci Polym Ed; 1997; 8(7):545-53. PubMed ID: 9195333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmatic antiproteinase activity enhancement by insoluble functionalized polystyrene surfaces.
    Charef S; Jozefowicz M; Labarre D; Tapon-Bretaudiere J; Fischer AM; Bros A
    Biomaterials; 1990 Aug; 11(6):425-9. PubMed ID: 2207233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fragment of antithrombin that binds both heparin and thrombin.
    Rosenfeld L; Danishefsky I
    Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory mechanism of serpins. Interaction of thrombin with antithrombin and protease nexin 1.
    Stone SR; Hermans JM
    Biochemistry; 1995 Apr; 34(15):5164-72. PubMed ID: 7711036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.